Today's Portrait Highlights

Innovation Synergy Foundation

The Innovation Synergy Foundation was established to support young scientist and graduate students in development of innovative Life Science projects with high potential of applicability and commercial value. Our efforts focus on health technologies, pharmacy and biotech sectors. With the SynergyPlatform programme we support entrepreneurial development of the scientific community and assist in scientific grants applications with a great help from the Foundation Scientific Board. Together with our partners PRO SCIENCE Poland LTD and VTTF Fund we offer a full range of services in technology transfer, business consulting and investment. Contact us at: office@innovationsynergy.org

Skulle Implants Corporation

Skulle Implant Corporation sales, designs and manufactures one-of-a-kind sandwich designed craniomaxillofacial (CMF) –implants (Glace Implants) that delivers outstanding functionality and aesthetics to improve patients’ quality of life. Glace implant is a unique combination of biostable composite material and dissolving bioactive glass. Biostable glass fiber-reinforced composite is made to provide durable and anatomically formed over-lay structure for the implant. Bioactive and antimicrobial part of Glace implant is tailored bioactive glass, which has been shown clinically to be the superior among many different bioceramic compositions. Glace Implants enhance bone growth. Skulle Implants provides two lines of GLACETM implants: (1) Patient specific, GLACETM Custom Made –implants: Made to measure in any shape, structure or form. Durable yet lightweight regardless of implant size. Which are manufactured according to 3D model made from the patient´s CT-scan; (2) GLACETM standard –implants: Range of 15 different shape and sizes to ensure perfect fit. Product line has cranial implants, orbital floor plates and burr hole covers.

RIEMSER Pharma GmbH

RIEMSER Pharma GmbH, headquartered in Greifswald, Germany, is a midsize pharmaceutical company specialized in marketing and sophisticated life cycle management of specialty drugs for treatment of highly complex and niche disease areas. RIEMSER targets European markets but its products are distributed worldwide by a wide-ranging partner network. Our success and our ability to respond dynamically to new challenges are based on the expertise, experience and commitment of our employees. As Specialty Pharma Company, we specialise in medicinal products for the management of malignant diseases (oncology), infectious diseases (anti-infectives), skin conditions (dermatology)and dental products. Other important segments of our range of products include analgesics, cardiovascular products and OTC medicines.